Literature DB >> 8437826

Microbial keratitis in childhood.

O A Cruz1, S M Sabir, H Capo, E C Alfonso.   

Abstract

BACKGROUND: Microbial keratitis occurs infrequently in childhood. The leading ocular predisposing factors are trauma and preexisting corneal disease. Many of the age-related risk factors in adults play a minor role in children.
METHODS: The authors retrospectively studied 51 eyes with ulcerative keratitis in 50 children younger than 16 years of age. This includes all patients treated at Bascom Palmer Eye Institute during an 11 1/2-year period from January 1, 1980, to June 30, 1991. The criterion for inclusion in the study was a discharge diagnosis of microbial (nonviral) keratitis.
RESULTS: The principal risk factors identified in this study were trauma (44%), prior corneal surgery (24%), systemic illness (14%), and contact lens wear (12%). Systemic illness or an immunocompromised state existed in 7 (47%) of the 15 children younger than 3 years of age. There was a large male preponderance (68%). Forty-four (86.3%) of the 51 eyes were culture-positive; six (11.7%) were polymicrobial. Five of seven culture-negative patients had received prior topical antibiotic therapy. Pseudomonas aeruginosa (34%), Staphylococcus aureus (20%), and fungi (18%) were the most common organisms isolated. Seven (14%) eyes required surgery.
CONCLUSION: This study presents important differentiating factors between adult and childhood nonviral microbial keratitis. Identification of principal risk factors in children may aid in early recognition and treatment of microbial keratitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8437826     DOI: 10.1016/s0161-6420(93)31671-4

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  19 in total

Review 1.  Keratitis due to Shigella flexneri.

Authors:  Harry L Muytjens; Catharina A Eggink; Frederik C A P Dijkman; Judith M J E Bakkers; Willem J G Melchers
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

2.  Characteristic clinical features as an aid to the diagnosis of suppurative keratitis caused by filamentous fungi.

Authors:  P A Thomas; A K Leck; M Myatt
Journal:  Br J Ophthalmol       Date:  2005-12       Impact factor: 4.638

Review 3.  The persistent dilemma of microbial keratitis: Global burden, diagnosis, and antimicrobial resistance.

Authors:  Lawson Ung; Paulo J M Bispo; Swapna S Shanbhag; Michael S Gilmore; James Chodosh
Journal:  Surv Ophthalmol       Date:  2018-12-24       Impact factor: 6.048

Review 4.  Corneal ulceration in pediatric patients: a brief overview of progress in topical treatment.

Authors:  Serina Stretton; Usha Gopinathan; Mark D P Willcox
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

5.  Corneal ulceration in the elderly in Hyderabad, south India.

Authors:  D Y Kunimoto; S Sharma; P Garg; U Gopinathan; D Miller; G N Rao
Journal:  Br J Ophthalmol       Date:  2000-01       Impact factor: 4.638

6.  A novel mechanism of increased infections in contact lens wearers.

Authors:  Gabriel M Gordon; Navid Moradshahi; Shinwu Jeong; Christianne Lane; M Elizabeth Fini
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-25       Impact factor: 4.799

7.  Photorefractive keratectomy for anisometropic amblyopia in children.

Authors:  Evelyn A Paysse
Journal:  Trans Am Ophthalmol Soc       Date:  2004

8.  Paediatric bacterial keratitis cases in Shanghai: microbiological profile, antibiotic susceptibility and visual outcomes.

Authors:  J Hong; J Chen; X Sun; S X Deng; L Chen; L Gong; W Cao; X Yu; J Xu
Journal:  Eye (Lond)       Date:  2012-10-19       Impact factor: 3.775

9.  Non-viral microbial keratitis in children.

Authors:  Abdullah G Al-Otaibi
Journal:  Saudi J Ophthalmol       Date:  2011-10-13

10.  Antimicrobial management of presumed microbial keratitis: guidelines for treatment of central and peripheral ulcers.

Authors:  H G Bennett; J Hay; C M Kirkness; D V Seal; P Devonshire
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.